RecruitingPhase 4NCT06036095

Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study

Optimizing Anesthesia to Prevent Postoperative Cognitive and Functional Decline in Older Adults: A Randomized Controlled Trial


Sponsor

Oregon Health and Science University

Enrollment

260 participants

Start Date

Aug 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Traditionally, general anesthesia is maintained with inhalational anesthesia (GAS), but there is a gap in knowledge regarding whether intravenous anesthesia (IV) can prevent deleterious postoperative outcomes in the geriatric surgical population. The goal of this clinical trial is to determine whether intravenous anesthesia (IV) leads to a decreased incidence of postoperative delirium (POD), postoperative cognitive dysfunction (POCD), and functional decline, and improved patient-reported outcomes (PROs) in older adults undergoing non-cardiac surgery when compared to the standard inhalational anesthesia (GAS). This single-center, 1:1 randomized, double-blind (patient \& outcome assessor) clinical trial will compare inhalational vs. intravenous anesthesia on POD, POCD, functional status, patient-reported outcomes (PROs), and blood-based biomarkers in older patients undergoing elective, inpatient, non-cardiac surgery. Upon enrollment, 260 women and men ≥ 70 years undergoing elective noncardiac surgery under general anesthesia will be randomized to 2 groups: TIVA or GAS.


Eligibility

Min Age: 70 YearsMax Age: 110 Years

Inclusion Criteria4

  • Men and women ≥ 70 years
  • Sufficient vision and hearing to complete all tests
  • Proficient in spoken and written English
  • Scheduled for elective, inpatient, noncardiac surgery, expected to last at least 120 minutes requiring general anesthesia

Exclusion Criteria11

  • Urgent or emergent surgery
  • Diagnosed dementia (or MoCA<19)
  • History of Parkinson's disease, major psychiatric disease (Schizophrenia), or severe traumatic brain injury
  • Ongoing alcohol or substance abuse (per DSM V criteria)
  • Allergy to propofol or sevoflurane
  • Personal or family history of malignant hyperthermia
  • Planned postoperative intubation
  • Brain surgery
  • Surgery requiring TIVA or GAS (i.e. cases involving neuromonitoring)
  • Surgical procedure requiring general anesthetic occurring within 3 months (before or after) surgical date
  • Any patient or perioperative factor considered a contraindication to randomization to either experimental group by the surgeon or anesthesiologist.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSevoflurane

Inhalational maintenance of anesthesia group using sevoflurane

DRUGPropofol

Intravenous maintenance of anesthesia group using propofol


Locations(1)

Oregon Health & Science University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06036095


Related Trials